Fig. 4From: A novel Chr1-miR-200 driven whole transcriptome signature shapes tumor immune microenvironment and predicts relapse in early-stage lung adenocarcinomaOverall survival relative to WISP miR-200-signature, (low proportion of miR-200-signature-up = mir200-sign-down; high proportion of miR-200-signature-up = mir200-sign-up) in TCGA data: (A) < 50% down or > 50% up, (B) divided in quartilesBack to article page